On Carlsbad's Faraday Avenue biotech corridor, Prescient Medicine PersonalizeDx Labs develops pharmacogenomic and molecular diagnostic tests from three CLIA-certified laboratories, including its local facility established in 1987 as AutoGenomics. The lab's FDA 510(k)-exempt INFINITI microarray platform automates multiplexed genetic analysis across oncology, pain management, and cardiovascular panels, generating prescribing guidance that feeds into primary care workflows at Kaiser Permanente Carlsbad Medical Offices and other North County providers. The parent entity rebranded as SOLVD Health, building on the AutoGenomics acquisition to focus its Carlsbad operations on precision medicine diagnostics. The LifeKit PreScript pharmacogenomic test screens broad medication classes to identify patients at risk for adverse drug reactions before prescriptions are written. ToxKit, the company's advanced drug screening tool, pairs with its PGx panels to give clinicians a dual lens on medication metabolism, a workflow that complements diagnostic imaging at Carlsbad Imaging Center when structural findings require pharmaceutical intervention. The AvertD test received FDA approval as the first genetically validated assessment for opioid use disorder risk, analyzing neural-reward pathway mutations to identify susceptibility before opioid prescribing.